Brief: SyntheticMR Gains Further Clearance From FDA For Its Software SyMRI
June 13 (Reuters) - SYNTHETICMR AB (PUBL) SYNTH.TE :
* SAID ON TUESDAY CO HAD GAINED FURTHER CLEARANCE FROM FDA
FOR ITS
SOFTWARE SYMRI
* SAID CLEARANCE CONCERNED THE CLINICAL USE OF SYMRI
TOGETHER WITH
PHILIPS MR SCANNERS
Source text for Eikon: urn:newsml:reuters.com:*:nWkr5PXT9M
Further company coverage: SYNTH.TE
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))